Homoserine Lactone

Homoserine Lactone

SCHEMBL1034274

Br.NC1CCOC1=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Homoserine Lactone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107973733-B Method for preparing selenomethionine 四川新一美生物科技有限公司 2020-04-17 CN claimed
US-20240124408-A1 Substituted Cyclohexanecarboxamides, Their Preparation and Their Therapeutic Application SANOFI (FR) 2024-04-18 US disclosed
CN-115677548-B Efficient synthesis method of selenomethionine 湖南农业大学 2024-04-09 CN disclosed
EP-4263493-A1 SUBSTITUTED CYCLOHEXANECARBOXAMIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION Sanofi (FR) 2023-10-25 EP disclosed
WO-2023097207-A1 SYNTHETIC PROCESS FOR PRODUCTION OF MODIFIED GCC RECEPTOR AGONISTS IRONWOOD PHARMACEUTICALS, INC. (US) 2023-06-01 WO disclosed
US-20230138795-A1 DOPAMINE-B-HYDROXYLASE INHIBITORS BIAL PORTELA & CA SA (PT) 2023-05-04 US disclosed
US-11434242-B2 Dopamine-b-hydroxylase inhibitors BIAL—PORTELA & CA, S.A. (PT) 2022-09-06 US disclosed
WO-2022133027-A1 SUBSTITUTED CYCLOHEXANECARBOXAMIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2022-06-23 WO disclosed
CN-111138332-B Seleno-glycyrrhetinic acid, preparation method and application thereof 山东兴安动物药业有限公司 2021-10-26 CN disclosed
US-20210171528-A1 DOPAMINE-B-HYDROXYLASE INHIBITORS BIAL - PORTELA & CA, S.A. (PT) 2021-06-10 US disclosed
EP-0151964-A2 New derivatives of alpha-amino-gamma-butyrolactone, method for the preparation thereof and pharmaceutical compositions containing them Laboratorio Farmaceutico C.T. s.r.l. (IT) 1985-08-21 EP disclosed
US-4474801-A ALCOHOLISM ISTITUTO CHEMIOTERAPICO ITALIANO, SPA (IT) 1984-10-02 US disclosed
US-4290957-A SWEETENERS DYNAPOL (US) 1981-09-22 US disclosed
US-4267165-A Comestibles sweetened with alpha amino acid dihydrochalcones DYNAPOL (US) 1981-05-12 US disclosed
US-4226804-A ARTIFICIAL SWEETENER DYNAPOL (US) 1980-10-07 US disclosed
US-4180579-A 2-Substituted-1H-benz[de]-isoquinoline-1,3(2H)-diones E. R. SQUIBB & SONS, INC. (US) 1979-12-25 US disclosed
US-4170651-A ANTIINFLAMMATORY AGENTS E. R. SQUIBB & SONS, INC. (US) 1979-10-09 US disclosed
US-4115555-A ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1978-09-19 US disclosed
US-4051246-A ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1977-09-27 US disclosed
US-3968233-A α-Amino-γ-butyrolactones as sedatives ISTITUTO CHEMIOTERAPICO ITALIANO (IT) 1976-07-06 US disclosed